CAMP Q4 2021 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$69M-21.9% YoY

Gross Profit

$28M40.7% margin

Operating Income

-$7M-9.5% margin

Net Income

-$11M-16.6% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

-13.0%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$11M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$402M

Total Liabilities

$322M

Stockholders' Equity

$80M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$69M	$88M	-21.9%
Gross Profit	$28M	$35M	-20.0%
Operating Income	-$7M	-$20M	+67.2%
Net Income	-$11M	-$24M	+51.7%

Revenue Segments

Product

$40M59%

Application Subscriptions And Other Services

$28M41%

Geographic Segments

U S

$45M65%

E M E A

$12M18%

Asia Pacific

$6M8%

L A S F

$6M8%

All Other

$770,0001%